TickrTrends BDX fair value analysis

Envetec Receives California Approval for GENERATIONS® to Treat Biohazardous and Sharps Waste

manilatimes.net · 2026-08-12

Approval expands Envetec’s US regulatory footprint and its ability to serve major healthcare and life sciences organizations

TickrTrends take: Becton Dickinson's subsidiary Envetec obtained California regulatory approval for GENERATIONS technology to process biohazardous and sharps waste, expanding the company's addressable market in medical waste management. This approval represents progress in BD's diversification beyond traditional medical devices and diagnostics into waste treatment solutions, a segment that could support recurring revenue streams from healthcare facilities. For investors focused on valuation, the expansion of BD's waste management capabilities warrants monitoring as a potential growth driver that may not yet be fully reflected in the company's current undervalued assessment.

Read the full story at manilatimes.net →

Is BDX undervalued? See TickrTrends' fair value analysis →